FDA Approval And Global Expansion Will Unlock New Markets

AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Published
02 May 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
AU$0.19
13.9% undervalued intrinsic discount
08 Aug
AU$0.17
Loading
1Y
37.5%
7D
6.5%

Author's Valuation

AU$0.2

13.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 Aug 25
Fair value Increased 5.50%

Despite a decline in net profit margin, a higher future P/E ratio reflects improved earnings expectations for Bubs Australia, driving the consensus analyst price target up from A$0.182 to A$0.192. What's in the News Bubs Australia appointed Joe Coote as its new CEO, replacing Reg Weine.